Curis, Inc. (CRIS)

CAPS Rating:

A drug discovery and development company that is seeking to leverage its innovative biological signaling pathway drug technologies to create new medicines primarily in the field of cancer.

View All Commentary (CRIS)

Recs

2

Avatar darkflame (98.89) Submitted: 5/14/07 9:21 AM : Start Price: $2.21 CRIS Score: -13.31

Losing 30 points on this one, why did I buy it ? I don't know... Ok, let's be honest, because a friend likes this company. Slowly he is getting bold and as he last hope he invests in this company. Shall this company be successfull he will drive a sports car and have beautfull brilliant hair, otherwise no money nor hair.

But...trying to figure out a logical reason for CAPsing this stock, well, insiders own something of it and during 2006 bought a bit more, but really just a bit.

What is this company achieving ?

From 2004 to 2006 it tripled the revenue and decreased the cost of that revenue and has managed to narrow it's loss like a good biotech company would do.

Price/Book value is 2.15. The question is if that book value is worth anything for an investor, but we are optimist today aren't we ?

Entreprise Value / Revenue is 2.65. Not bad...

What does this company need to be worth anything for you or for me ? Quick answer, keep increasing the revenue for about the same rate.

Keep this company in mind.

Report this Post Replies: 1 | Reply

Avatar darkflame (98.89) Submitted: 5/16/07 11:44 AM

Recs: 0 | Rec This

...if this company keeps going down like this, one of these days I buy it for free.

Report this Post Reply

Curis, Inc. (CRIS)

2

Featured Broker Partners